UNSPSC 51282414: Carbenicillin indanyl

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C26H26N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V278481KE, chemically known as 1-(5-indanyl)(2s,5r,6r)-n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamate, but more generally known as carbenicillin indanyl, which bears US NIH Compound Identifier 93184.

UNSPSC 51282414 Carbenicillin indanyl is a Commodity code that nominally identifies a single antibiotic product, but the recent state and local opportunities posted under it span a much broader range of pharmaceutical procurement — generic multi-source drugs, over-the-counter products, naloxone, medical and first aid supplies, and direct-to-manufacturer prescription programs. State and local buyers using this code tag solicitations for pharmaceutical inventory, emergency response medical supplies, and pharmacy benefit program design rather than carbenicillin specifically. Issuing bodies include state health and human services agencies (Texas HHS Commission, Minnesota Department of Administration), county health departments (Seminole County, Florida), municipal fire and rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (MMCAP). The work being solicited ranges from annual supply contracts for discrete medical products to complex multi-vendor agreements with wholesalers and manufacturers serving statewide or multistate populations.

Recent activity concentrates in Florida, Texas, and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP posted January 20, 2026, due March 26, 2026, to establish multiple contracts for generic pharmaceuticals and OTC products distributed across participating state and local facilities, requiring vendors to supply through three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act standards. Seminole County, Florida posted an IFB (Solicitation IFB60459723LAS) on June 30, 2026, due July 26, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the estimated contract value was not disclosed but is potentially FEMA-funded. The City of Tampa Purchasing Department issued an IFB (26P00145) posted March 25, 2026, due March 13, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a sheltered-market set-aside for certified Small Local Business Enterprises. The Texas HHS Commission posted an RFI (HHS0017013) on April 3, 2026 seeking vendor capabilities for a direct-to-manufacturer pharmacy initiative outside traditional pharmacy benefit manager and group purchasing organization channels.